Caspase-6 activation in familial alzheimer disease brains carrying amyloid precursor protein or presenilin i or presenilin II mutations

Steffen Albrecht, Nenad Bogdanovic, Bernardino Ghetti, Bengt Winblad, Andréa C. Leblanc

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

We previously demonstrated the activation of caspase-6 (Casp-6) in the hippocampus and cortex in cases of mild, moderate, severe, and very severe Alzheimer disease (AD). To determine whether Casp-6 is also activated in familial AD, we performed an immunohistochemical analysis of active Casp-6 and Tau cleaved by Casp-6 in temporal cortex and hippocampal tissue sections from cases of familial AD. The cases included 5 carrying the amyloid precursor protein K670N and M671L Swedish mutation, 1 carrying the amyloid precursor protein E693G Arctic mutation, 2 each carrying the Presenilin I M146V, F105L, A431E, V261F, and Y115C mutations, and 1 with the Presenilin II N141I mutation. Active Casp-6 immunoreactivity was found in all cases. Caspase-6 immunoreactivity was observed in neuritic plaques or in some cases cotton-wool plaques, and in neuropil threads and neurofibrillary tangles. These results indicate that Casp-6 is activated in familial forms of AD, as previously observed in sporadic forms. Because sporadic and familial AD cases have similar pathological features, these results support a fundamental role of Casp-6 in the pathophysiology of both familial and sporadic AD.

Original languageEnglish
Pages (from-to)1282-1293
Number of pages12
JournalJournal of Neuropathology and Experimental Neurology
Volume68
Issue number12
DOIs
StatePublished - Dec 2009

Fingerprint

Caspase 6
Presenilins
Amyloid beta-Protein Precursor
Alzheimer Disease
Mutation
Brain
Neuropil Threads
Presenilin-1
Neurofibrillary Tangles
Wool
Amyloid Plaques
Temporal Lobe
Hippocampus

Keywords

  • Alzheimer disease
  • Arctic mutation
  • Casp-6
  • Familial Alzheimer disease
  • Presenilin I mutation
  • Sporadic Alzheimer disease
  • Swedish mutation
  • Tau cleaved by Casp-6

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Clinical Neurology
  • Neurology
  • Cellular and Molecular Neuroscience

Cite this

Caspase-6 activation in familial alzheimer disease brains carrying amyloid precursor protein or presenilin i or presenilin II mutations. / Albrecht, Steffen; Bogdanovic, Nenad; Ghetti, Bernardino; Winblad, Bengt; Leblanc, Andréa C.

In: Journal of Neuropathology and Experimental Neurology, Vol. 68, No. 12, 12.2009, p. 1282-1293.

Research output: Contribution to journalArticle

@article{c732b7eb19b24efb8f75272407d23fda,
title = "Caspase-6 activation in familial alzheimer disease brains carrying amyloid precursor protein or presenilin i or presenilin II mutations",
abstract = "We previously demonstrated the activation of caspase-6 (Casp-6) in the hippocampus and cortex in cases of mild, moderate, severe, and very severe Alzheimer disease (AD). To determine whether Casp-6 is also activated in familial AD, we performed an immunohistochemical analysis of active Casp-6 and Tau cleaved by Casp-6 in temporal cortex and hippocampal tissue sections from cases of familial AD. The cases included 5 carrying the amyloid precursor protein K670N and M671L Swedish mutation, 1 carrying the amyloid precursor protein E693G Arctic mutation, 2 each carrying the Presenilin I M146V, F105L, A431E, V261F, and Y115C mutations, and 1 with the Presenilin II N141I mutation. Active Casp-6 immunoreactivity was found in all cases. Caspase-6 immunoreactivity was observed in neuritic plaques or in some cases cotton-wool plaques, and in neuropil threads and neurofibrillary tangles. These results indicate that Casp-6 is activated in familial forms of AD, as previously observed in sporadic forms. Because sporadic and familial AD cases have similar pathological features, these results support a fundamental role of Casp-6 in the pathophysiology of both familial and sporadic AD.",
keywords = "Alzheimer disease, Arctic mutation, Casp-6, Familial Alzheimer disease, Presenilin I mutation, Sporadic Alzheimer disease, Swedish mutation, Tau cleaved by Casp-6",
author = "Steffen Albrecht and Nenad Bogdanovic and Bernardino Ghetti and Bengt Winblad and Leblanc, {Andr{\'e}a C.}",
year = "2009",
month = "12",
doi = "10.1097/NEN.0b013e3181c1da10",
language = "English",
volume = "68",
pages = "1282--1293",
journal = "American Journal of Psychotherapy",
issn = "0002-9564",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Caspase-6 activation in familial alzheimer disease brains carrying amyloid precursor protein or presenilin i or presenilin II mutations

AU - Albrecht, Steffen

AU - Bogdanovic, Nenad

AU - Ghetti, Bernardino

AU - Winblad, Bengt

AU - Leblanc, Andréa C.

PY - 2009/12

Y1 - 2009/12

N2 - We previously demonstrated the activation of caspase-6 (Casp-6) in the hippocampus and cortex in cases of mild, moderate, severe, and very severe Alzheimer disease (AD). To determine whether Casp-6 is also activated in familial AD, we performed an immunohistochemical analysis of active Casp-6 and Tau cleaved by Casp-6 in temporal cortex and hippocampal tissue sections from cases of familial AD. The cases included 5 carrying the amyloid precursor protein K670N and M671L Swedish mutation, 1 carrying the amyloid precursor protein E693G Arctic mutation, 2 each carrying the Presenilin I M146V, F105L, A431E, V261F, and Y115C mutations, and 1 with the Presenilin II N141I mutation. Active Casp-6 immunoreactivity was found in all cases. Caspase-6 immunoreactivity was observed in neuritic plaques or in some cases cotton-wool plaques, and in neuropil threads and neurofibrillary tangles. These results indicate that Casp-6 is activated in familial forms of AD, as previously observed in sporadic forms. Because sporadic and familial AD cases have similar pathological features, these results support a fundamental role of Casp-6 in the pathophysiology of both familial and sporadic AD.

AB - We previously demonstrated the activation of caspase-6 (Casp-6) in the hippocampus and cortex in cases of mild, moderate, severe, and very severe Alzheimer disease (AD). To determine whether Casp-6 is also activated in familial AD, we performed an immunohistochemical analysis of active Casp-6 and Tau cleaved by Casp-6 in temporal cortex and hippocampal tissue sections from cases of familial AD. The cases included 5 carrying the amyloid precursor protein K670N and M671L Swedish mutation, 1 carrying the amyloid precursor protein E693G Arctic mutation, 2 each carrying the Presenilin I M146V, F105L, A431E, V261F, and Y115C mutations, and 1 with the Presenilin II N141I mutation. Active Casp-6 immunoreactivity was found in all cases. Caspase-6 immunoreactivity was observed in neuritic plaques or in some cases cotton-wool plaques, and in neuropil threads and neurofibrillary tangles. These results indicate that Casp-6 is activated in familial forms of AD, as previously observed in sporadic forms. Because sporadic and familial AD cases have similar pathological features, these results support a fundamental role of Casp-6 in the pathophysiology of both familial and sporadic AD.

KW - Alzheimer disease

KW - Arctic mutation

KW - Casp-6

KW - Familial Alzheimer disease

KW - Presenilin I mutation

KW - Sporadic Alzheimer disease

KW - Swedish mutation

KW - Tau cleaved by Casp-6

UR - http://www.scopus.com/inward/record.url?scp=73349135640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73349135640&partnerID=8YFLogxK

U2 - 10.1097/NEN.0b013e3181c1da10

DO - 10.1097/NEN.0b013e3181c1da10

M3 - Article

VL - 68

SP - 1282

EP - 1293

JO - American Journal of Psychotherapy

JF - American Journal of Psychotherapy

SN - 0002-9564

IS - 12

ER -